GlassScriptPhysician profile
Melissa B Mcclenahan
NPI 1053695676
$18,611.23
in general payments reported to CMS, 2019-2025
31 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $450 · 2023: $2,150 · 2024: $621 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,820 · Travel and Lodging: $6,669 · Food and Beverage: $3,056 · Consulting Fee: $250 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,820.00 |
| Travel and Lodging | $6,669.06 |
| Food and Beverage | $3,056.28 |
| Consulting Fee | $250.00 |
| Education | $150.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $14,324.24 | 2022-2025 | Rybrevant, Carvykti, Erleada |
| Boston Scientific Corporation | $1,247.63 | 2023 | Ams 700 Cxr Rte Kit |
| Abbvie INC. | $688.51 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $322.00 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $271.63 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $226.08 | 2021-2025 | Provenge |
| Pfizer INC. | $206.01 | 2022-2024 | |
| Astellas Pharma US INC | $166.86 | 2022-2025 | Veozah, Xtandi |
| Merck Sharp & Dohme LLC | $147.78 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $147.75 | 2022-2024 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $124.99 | 2021 | |
| Endo USA, INC. | $98.36 | 2024-2025 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $95.71 | 2024-2025 | |
| Axsome Therapeutics, INC. | $56.72 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $54.08 | 2024-2025 | Rexulti |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $47.40 | 2025 | Itind System |
| Genzyme Corporation | $45.95 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $43.53 | 2022-2025 | Lynparza |
| Vanda Pharmaceuticals INC. | $40.45 | 2025 | Fanapt |
| Bluewind Medical | $39.31 | 2025 | Revi |
| Myovant Sciences INC. | $31.72 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $29.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $27.82 | 2022-2023 | Xiaflex, Aveed |
| Novo Nordisk INC | $24.29 | 2025 | Rivfloza |
| Immunitybio, INC. | $19.75 | 2025 | |
| Bioprotect Medical, INC. | $18.94 | 2025 | Bioprotect Balloon Implant System |
| Telix Pharmaceuticals | $16.80 | 2022 | |
| Teleflex LLC | $15.06 | 2021 | |
| Urovant Sciences INC | $13.01 | 2022 | |
| Allergan, INC. | $11.80 | 2021 | |
| Travere Therapeutics, INC. | $7.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Mcclenahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.